Dr Michael Dillon
Profiles

Dr Michael Dillon

Lecturer in Infection and Immunity

Peninsula Medical School (Faculty of Health)

Biography

Biography

Michael joined Peninsula Medical School in September 2020 as a Lecturer in Infection and Immunity, where he teaches infectious disease pathogenesis and immunology across a wide range of programmes, including BMBS Undergraduate Medicine, Physicians Associates, and MSc Global Heath. Michael has a non-clinical research background and has previously developed multiple diagnostic test kits for early human and veterinary disease detection in resource-poor settings. 

Qualifications

PhD Cellular & Molecular Biology | BSc Chemical Engineering | PgCert Clinical Education

Professional membership

Royal Society of Biology (Member) | AdvanceHE (Associate Fellow)

Teaching

Teaching

Teaching interests

Michael has over 10 years experience researching and teaching infectious disease pathogenesis, including microbiology, clinical microbiology, and tropical disease. He also has extensive experience with adaptive immunity and research ethics, and is particularly interested in research animal welfare and governance policy.

Michael also has a keen interest in emerging point-of-care (POC) technology, especially for use in resource-poor settings

Publications

Publications

Journals

Zaczek-Moczydlowska M, Beizaei A, Dillon M, Campbell, K. Current state-of-the-art diagnostics for Norovirus detection: Model approaches for point-of-care analysis. Trends in Food Science & Technology (2021), doi.org/10.1016/j.tifs.2021.06.027

Dillon MJ, Zaczek-Moczydlowska M, Edwards C., et al. Current Trends and Challenges for Rapid SMART Diagnostics at Point-of-Site Testing for Marine Toxins. MDPI sensors (2021), doi:10.3390/s21072499

Nelis JLD, Tsagkaris AS, Dillon MJ, Hajslova J, Elliot CT. Smartphone-based assays in the food safety field. TrAC Trends in Analytical Chemistry (2020), doi:10.1016/j.trac.2020.115934

Sheppard EC, Morrish RB, Dillon MJ, Leyland R, Chahwan R. Epigenomic modifications mediating antibody diversification. Frontiers in Immunology (2018), doi:10.3389/fimmu.2018.00355

Liew N, Moya M, Hollinshead M, Wierzbicki CJ, Hollinshead M, Dillon MJ, et al. Chytrid fungus infection in zebrafish demonstrates that the pathogen can parasitise non-amphibian vertebrate hosts. Nature Communications (2017), doi:10.1038/ncomms15048

Dillon MJ, Bowkett AE, Bungard MJ, Fisher MC, et al. Tracking amphibian pathogens Batrachochytrium dendrobatidis and Batrachochytrium salamandrivorans using highly specific monoclonal antibody and lateral-flow technology. Microbial biotechnology (2016), doi:10.1111/1751-7915.12463

Robertson G, Sorenson A, Govan B, Ketheesan N, Houghton R, Chen H, AuCoin D, Dillon MJ, et al. Rapid diagnostics for melioidosis: a comparative study of a novel flow antigen detection assay. Microbial Microbiology (2015), do:10.1099/jmm.0.000098

Dillon MJ, Loban RA, Reed DE, Brett PJ, et al.Contribution of murine IgG Fc regions to antibody binding to the capsule of Burkholderia pseudomallei. Virulence (2015), doi:10.1080/21505594.2016.1176655

Marchetti R, Dillon MJ, Burtnick MN, et al. Burkholderia pseudomallei Capsular Polysaccharide Recognition by a Monoclonal Antibody Reveals Key Details toward a Biodefense Vaccine and Diagnostics against Melioidosis. ACS Chem. Bio. (2015), doi:10.1021/acschembio.5b00502.

Houghton RL, Reed DE, Hubbard MA, Dillon MJ, et al. Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoS Negl Trop. Dis. (2014), 8, e2727